Phase 2 Trial of Oral Treatment for Ulcerative Colitis Now Recruiting

Phase 2 Trial of Oral Treatment for Ulcerative Colitis Now Recruiting
Lycera has announced the launch of a Phase 2 clinical trial to assess the effectiveness of its lead clinical-stage candidate, LYC-30937-EC (Enteric Coated), as a once daily oral treatment for patients with active ulcerative colitis (UC). The clinical trial is currently recruiting participants. “The initiation of the Phase 2 clinical trial of LYC-30937-EC is an important milestone in Lycera’s

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *